Expert-Led Psychopharmacology
Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment centers on the treatment of usual psychiatric patients with emphasis on the difficult to treat or treatment-resistant. Continuing medical education lectures will enhance your ability to choose treatments as you gain an understanding of the interface between psychiatric, neurological, and medical illness.
Legendary faculty review new antipsychotic medications and treatment augmentation, potential new uses for mood stabilizers, the neurobiologic mechanisms of depression and the role of inflammation, the importance of a therapeutic alliance when prescribing psychotropic medications, and more. With this online CME program, you’ll explore current evidence-based and emerging treatments for:
- Schizophrenia and bipolar disorder
- Bipolar and treatment-resistant depression
- TMS and ECT
- Anxiety spectrum and sleep disorders
- PTSD
- Alcohol and substance abuse disorders
- Women’s mental health issues
- Child, adolescent, and geriatric psychopharmacology
Who should attend this course
Learning Objectives
At the completion of this course, you should be able to:
- Describe lessons learned from genomic sequencing of patients with psychiatric illnesses
- Identify unsolved problems regarding the pharmacologic treatment of schizophrenia and learning more effective treatments
- Describe emerging theories and treatments of bipolar disorder, difficult-to-treat depression, bipolar depression, and anxiety disorder
- Outline the perils and possibilities of psychedelics and ketamine
- Recognize when to utilize ECT and TMS for treatment-resistant depression
- Illustrate emerging treatments for PTSD
- Review sleep disorders commonly comorbid with psychiatric illness, and appropriate use of medications and treatment
- Review interface of medicine and psychiatry with a focus on cancer, cardiovascular disease
- Review the interface of neurology and psychiatry with an emphasis on functional neurological disease, hysteria, movement disorders, pain, OCD and others
- Summarize the use of genetic tests, serum level measurements, and drug combinations in treatment-resistant depression
- Identify the current role of pharmacotherapy in the treatment of substance use disorders including alcohol, opioids, and cannabis
- Review the role of pharmacotherapy in the treatment of psychiatric disorders throughout women’s reproductive lifespan, with a focus on the premenstrual, prenatal, postpartum, and perimenopausal periods
- Examine the latest advances and problems associated with treatment approaches in the child, adolescent, and geriatric populations
Topics / Speakers
| Topic | Speaker |
|---|---|
| Lessons Learned from the DNA of Patients with Psychiatric Disorders | Daniel Weinberger, MD |
| Neurology and Psychiatry Interface | Martin Samuels, MD, DSc (hon) |
| The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease | Charles Nemeroff, MD, PhD |
| Tackling Unsolved Problems in Schizophrenia – Cognitive Impairment, Negative Symptoms, Partial Treatment Response | Philip Harvey, PhD |
| Panel Discussion | Philip Harvey, PhD; Charles Nemeroff, MD, PhD; Martin Samuels, MD, DSc (hon); Daniel Weinberger, MD |
| Pharmacological Treatment of Bipolar Disorder | Ross Baldessarini, MD, DSc (hon) |
| Anxiety – Treat the Symptom or Treat the Disorder When First Line Therapies Fail | Stephen M. Stahl, MD, PhD, DSc (hon) |
| Neurobiology and Treatment of Post-traumatic Stress Disorder | Charles Nemeroff, MD, PhD |
| Panel Discussion | Ross Baldessarini, MD, DSc (hon); Charles Nemeroff, MD, PhD |
| Psychopharmacologic Treatment of Sleep Disorders | Sogol Javaheri, MD |
| Treatment Resistant Depression | Stephen M. Stahl, MD, PhD, DSc (hon) |
| Psychedelics and Potential Drugs of Abuse as Antidepressants | Alan F. Schatzberg, MD |
| Pharmacotherapy of Substance Use Disorders | Roger D. Weiss, MD |
| Panel Discussion | Barbara Coffey, MD, MS; Sogol Javaheri, MD; Alan F. Schatzberg, MD; Stephen M. Stahl, MD, PhD, DSc (hon); Roger D. Weiss, MD |
| Child and Adolescent Psychopharmacology – Current Treatment for Best Practices | Barbara J. Coffey, MD, MS |
| Psychopharmacology Across the Reproductive Lifespan – From Menarche to Menopause | Ariadna Forray, MD |
| Geriatric Psychopharmacology | Elizabeth Crocco, MD |
| Panel Discussion | Barbara J. Coffey, MD, MS; Elizabeth Crocco, MD; Ariadna Forray, MD |
Meet the Course Experts:
| FACULTY | |
|---|---|
| Course Directors | |
|
Barbara J. Coffey, MD, MS Professor and Chairman Department of Psychiatry and Behavioral Sciences Chief, Division of Child and Adolescent Psychiatry University of Miami Miller School of Medicine |
Charles Nemeroff, MD, PhD Matthew P. Nemeroff Professor and Chair Department of Psychiatry and Behavioral Sciences Mulva Clinic for the Neurosciences Director, Institute of Early Life Adversity Research Dell Medical School The University of Texas at Austin |
| Faculty | |
|
Ross Baldessarini, MD, DSc (hon) Professor of Psychiatry and Neuroscience Harvard Medical School Director, Psychopharmacology Program and International Consortium for Mood & Psychotic Disorder Research McLean Hospital |
Martin Samuels, MD, DSc (hon) Founding Chair Department of Neurology Brigham and Women’s Hospital Miriam Sydney Joseph Professor of Neurology Harvard Medical School |
|
Elizabeth Crocco, MD Clinical Professor Chief of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences University of Miami (UM) Miller School of Medicine Medical Director UM Memory Disorders Clinic Center for Cognitive Neuroscience & Aging (CNSA) Geriatric Psychiatry Training Director UM/Jackson Memorial Hospital |
Alan F. Schatzberg, MD Kenneth T. Norris Jr. Professor Department of Psychiatry and Behavioral Sciences Stanford University |
|
Ariadna Forray, MD Associate Professor of Psychiatry Interim Section Chief of Psychological Medicine Director, Center for Well-being of Women and Mothers Yale School of Medicine |
Stephen M. Stahl, MD, PhD, DSc (hon) Professor of Psychiatry University of California, San Diego Honorary Visiting Senior Fellow University of Cambridge, UK |
|
Philip Harvey, PhD Leonard M. Miller Professor of Psychiatry Department of Psychiatry and Behavioral Sciences VA Senior Health Scientist University of Miami Miller School of Medicine |
Daniel Weinberger, MD Professor of Psychiatry, Neurology, Neuroscience and Genetic Medicine Johns Hopkins University Director and CEO of the Lieber Institute for Brain Development |
|
Sogol Javaheri, MD Instructor in Medicine Harvard Medical School Associate Program Director Sleep Medicine Fellowship Brigham and Women’s Hospital |
Roger D. Weiss, MD Professor of Psychiatry Harvard Medical School Chief, Division of Alcohol, Drugs, and Addiction McLean Hospital |
Why Take This Course?
Living Legends in Psychopharmacology gives you the fastest, most reliable way to upgrade your prescribing skills with proven, evidence-based strategies taught by the world’s top psychiatric experts.
Learn from the leaders
Harvard, Stanford, Yale, Johns Hopkins, and UCSD faculty teach you exactly how they treat complex patients.
Master difficult cases
Get clear guidance for treatment-resistant depression, bipolar disorder, schizophrenia, anxiety, PTSD, sleep disorders, and substance use.
Stay ahead of the field
Understand emerging treatments—ketamine, psychedelics, TMS, ECT, genomic testing, and new antipsychotic approaches.
Treat across the lifespan
Confidently manage medications for children, adolescents, adults, women’s mental health, and geriatric patients.
Make better decisions
Learn how to handle comorbid psychiatric–medical–neurological conditions with precision and clarity.
Reviews
There are no reviews yet.